Who is sponsoring NCT05571657?

NCT05571657 is sponsored by Marshfield Clinic Research Foundation.

What drugs are being tested in NCT05571657?

Interventions in NCT05571657: Reminder/Recall Sent Via Preferred Method of Communication.

What condition does NCT05571657 study?

NCT05571657 studies COVID-19 Vaccines.

Is NCT05571657 still recruiting?

NCT05571657 is currently status unknown. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT05571657: AIMED COVID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Booster Dose Reminder/Recall for Adolescents

Status unknown NA Last updated 13 October 2022

What this trial tests

NA trial testing Reminder/Recall Sent Via Preferred Method of Communication in COVID-19 Vaccines in 4,304 participants. Status unknown.

Timeline

12 May 2022

Primary endpoint
30 August 2022

31 December 2022

Quick facts

Lead sponsor	Marshfield Clinic Research Foundation
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	4,304
Start date	12 May 2022
Primary completion	30 August 2022
Estimated completion	31 December 2022
Sites	1 location across United States

Drugs / interventions tested

Reminder/Recall Sent Via Preferred Method of Communication

Conditions studied

COVID-19 Vaccines — all drugs for COVID-19 Vaccines →

Sponsor

Marshfield Clinic Research Foundation

Who can join

Adults 12 to 17, any sex, with COVID-19 Vaccines. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single COVID-19 booster dose has been recommended in the United States for adolescents aged ≥12 years to enhance protection against SARS-CoV-2 infection. This study will assess the efficacy of a one-time reminder/recall for COVID-19 booster dose among eligible adolescents in a regional healthcare system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COVID-19 Vaccines

Currently open trials in the same condition.

NCT06923137 — A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much · active not recruiting
NCT05556720 — Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Contro · Phase 3 · active not recruiting
NCT05096260 — Getting to Yes, Michigan! (G2YMI) · NA · active not recruiting

Other Marshfield Clinic Research Foundation trials

Trials by the same sponsor.

NCT03641989 — Correlation Between Oral Health and Systemic Inflammation (COHESION) · NA · completed
NCT03598439 — Randomized Influenza Vaccine Evaluation of Immune Response · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05571657 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marshfield Clinic Research Foundation
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05571657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing